A cost-benefit analysis of the life-prolonging effect of nonsteroidal anti-inflammatory drugs for persons with dementia and pain

References

• Achterberg, W., S. Lautenbacher, B. Husebo, A. Erdal, and K. Herr. 2020. “Pain in Dementia.” PAIN: Clinical Updates R9 (5): (2020). e803. https://doi.org/10.1097/PR9.0000000000000803.
   Google Scholar
• Aldy, J. E., and W. K. Viscusi. 2008. “Adjusting the Value of a Statistical Life for Age and Cohort Effects.” The Review of Economics and Statistics 90 (3): 573–581. https://doi.org/10.1162/rest.90.3.573.
   Web of Science ®Google Scholar
• Alzheimer’s Association. 2023. “2023 Alzheimer’s Disease Facts and Figures.” Alzheimer’s Dementia 19 (4). https://doi.org/10.1002/alz.1.3016.
   Web of Science ®Google Scholar
• Austin, P. C. 2011. “An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies.” Multivariate Behavioral Research 46 (3): 399–424. https://doi.org/10.1080/00273171.2011.568786.
   PubMed Web of Science ®Google Scholar
• Barry, H. E., C. Parsons, A. P. A, and C. M. Hughes. 2016. “Exploring the Prevalence of and Factors Associated with Pain: A Cross-Sectional Study of Community-Dwelling People with Dementia.” Health & Social Care in the Community 24 (3): 270–282. https://doi.org/10.1111/hsc.12204.
   PubMed Web of Science ®Google Scholar
• Beekly, D. L., E. R. Ramos, W. W. Lee, et al. 2007. “The National Alzheimer’s Coordinating Center (NACC) Database: The Uniform Data Set.” Alzheimer Disease & Associated Disorders 21:249–258. https://doi.org/10.1097/WAD.0b013e318142774e.
   PubMed Web of Science ®Google Scholar
• Brent, R. J. 2022. Cost-Benefit Analysis and Dementia: New Interventions. Cheltenham, UK: Edward Elgar.
   Google Scholar
• Brent, R. J. 2023. “FDA-Approved Medications are Unlike Non-Pharmaceutical Interventions as They are Counterproductive.” Applied Economics 56 (16): 1935–1949. https://doi.org/10.1080/00036846.2023.2178625.
   Web of Science ®Google Scholar
• Brent, R. J. 2024a. “A Cost-Benefit Analysis of Beta-Blockers, Including the Benefits of Reducing the Symptoms of Dementia.” Applied Economics. https://doi.org/10.1080/00036846.2024.2311078.
   Web of Science ®Google Scholar
• Brent, R. J. 2024b. “An Economic Evaluation of Antipsychotic Medications Given to Persons with Dementia.” Applied Economics (forthcoming).https://doi.org/10.1080/00036846.2024.2339187.
   Web of Science ®Google Scholar
• Corbett, A., B. Husebo, M. Malcangio, A. Staniland, J. Cohen-Mansfield, D. Aarsland, C. Ballard, et al. 2012. “Assessment and Treatment of Pain in People with Dementia.” Nature Reviews Neurology 8 (5): 264–274. https://doi.org/10.1038/nrneurol.2012.53.
   PubMed Web of Science ®Google Scholar
• Cutler, D., A. Deaton, and A. Lleras-Muney. 2006. “The Determinants of Mortality.” Journal of Economic Perspectives 20 (3): 97–120. https://doi.org/10.1257/jep.20.3.97.
   Web of Science ®Google Scholar
• Defrin, R., M. Amanzio, M. de Tommaso, V. Dimova, S. Filipovic, D. P. Finn, L. Gimenez-Llort, et al. 2015. “Experimental Pain Processing in Individuals with Cognitive Impairment: Current State of the Science.” PAIN 156 (8): 1396–1408. https://doi.org/10.1097/j.pain.0000000000000195.
   PubMed Web of Science ®Google Scholar
• Eggleston, K. N., and V. R. Fuchs. 2012. “The New Demographic Transition: Most Gains in Life Expectancy Now Realized Late in Life.” Journal of Economic Perspectives 26 (3): 137–156. https://doi.org/10.1257/jep.26.3.137.
   PubMed Web of Science ®Google Scholar
• Greving, J. P., E. Buskens, H. Koffijberg, and A. Algra. 2008. “Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk.” Circulation 117 (22): 2875–2883. https://doi.org/10.1161/CIRCULATIONAHA.107.735340.
   PubMed Web of Science ®Google Scholar
• Hadjistavropoulos, T., K. Herr, K. M. Prkachin, K. D. Craig, S. J. Gibson, A. Lukas, and J. H. Smith. 2014. “Pain Assessment in Elderly Adults with Dementia.” Lancet Neurology 13 (12): 1216–1227. https://doi.org/10.1016/S1474-4422(14)70103-6.
   PubMed Web of Science ®Google Scholar
• Hummer, R. A., R. G. Rogers, and I. W. Eberstein. 1998. “Sociodemographic Differentials in Adult Mortality: A Review of Analytic Approaches.” Population & Development Review 24 (3): 553–578. https://doi.org/10.2307/2808154.
   Web of Science ®Google Scholar
• Morris, J. C. 1997. “Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type.” International Psychogeriatrics 9 (Suppl.1): 173–176. https://doi.org/10.1017/S1041610297004870.
   PubMedGoogle Scholar
• Morris, J. C., S. Weintraub, H. C. Chui, J. Cummings, C. DeCarli, S. Ferris, and N. L. Foster. 2006. “The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data from Alzheimer Disease Centers.” Alzheimer Disease & Associative Disorders 20 (4): 210–216. https://doi.org/10.1097/01.wad.0000213865.09806.92.
   PubMed Web of Science ®Google Scholar
• Rasu, R. S., K. Vouthy, A. N. Crowl, A. E. Stegeman, B. Fikru, W. A. Bawa, and M. E. Knell. 2014. “Cost of Pain Medication to Treat Adult Patients withNonmalignant Chronic Pain in the United States.” Journal of Managed Care Pharmacy 20 (9): 921–928. https://doi.org/10.18553/jmcp.2014.20.9.921.
   PubMed Web of Science ®Google Scholar
• Shaw, J. W., W. C. Horrace, and R. J. Vogel. 2005. “The Determinants of Life Expectancy: An Analysis of the OECD Health Data.” Southern Economic Journal 71 (4): 768–783. https://doi.org/10.1002/j.2325-8012.2005.tb00675.x.
   Web of Science ®Google Scholar
• Sun, M., W.-M. Chen, S.-Y. Wu, and J. Zhang. 2023. “Long-Term Opioid Use and Dementia Risk in Patients with Chronic Pain.” Journal of the American Medical Directors Association 24 (9): 1420–1426. https://doi.org/10.1016/j.jamda.2023.06.035.
   PubMed Web of Science ®Google Scholar
• Weintraub, S., D. Salmon, N. Mercaldo, S. Ferris, N. R. Graff-Radford, H. Chui, J. Cummings, et al. 2009. “The Alzheimer’s Disease Centers’ Uniform Data Set (UDS): The Neuropsychological Test Battery.” Alzheimer Disease & Associative Disorders 23 (2): 91. https://doi.org/10.1097/WAD.0b013e318191c7dd.
   PubMed Web of Science ®Google Scholar